Matthew M Walsh Organon & Co. (OGN) insider trading activity

Matthew M Walsh is Chief Financial Officer of Organon & Co.. Currently has a direct ownership of 91,974 shares of OGN, which is worth approximately $1.56 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 3,541 shares (Common Stock) at a price of $20.35 per share, resulting in proceeds of $72,059. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92K

4.13% 3M change

75.49% 12M change

Total Value Held $1.56 Million

MATTHEW M WALSH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 03 2024	SELL Payment of exercise price or tax liability	$72,059 $20.35 p/Share	3,541 Reduced 3.71%	91,974 Common Stock
Sep 03 2024	BUY Grant, award, or other acquisition	-	7,189 Added 7.0%	95,515 Common Stock
May 04 2024	SELL Payment of exercise price or tax liability	$80,263 $19.61 p/Share	4,093 Reduced 4.43%	88,326 Common Stock
May 04 2024	BUY Exercise of conversion of derivative security	-	8,310 Added 8.25%	92,419 Common Stock
Mar 31 2024	SELL Payment of exercise price or tax liability	$183,337 $18.8 p/Share	9,752 Reduced 10.39%	84,109 Common Stock
Mar 31 2024	BUY Exercise of conversion of derivative security	-	19,799 Added 18.03%	90,042 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$205,529 $18.04 p/Share	11,393 Reduced 13.33%	74,062 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	-	33,044 Added 27.89%	85,455 Common Stock
Aug 05 2023	SELL Payment of exercise price or tax liability	$236,959 $21.53 p/Share	11,006 Reduced 17.35%	52,411 Common Stock
Aug 05 2023	BUY Exercise of conversion of derivative security	-	22,347 Added 26.06%	63,417 Common Stock
May 04 2023	SELL Payment of exercise price or tax liability	$98,002 $24.24 p/Share	4,043 Reduced 8.96%	41,070 Common Stock
May 04 2023	BUY Exercise of conversion of derivative security	-	8,310 Added 15.56%	45,113 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$61,327 $23.09 p/Share	2,656 Reduced 6.73%	36,803 Common Stock
Mar 31 2023	BUY Exercise of conversion of derivative security	-	7,753 Added 16.42%	39,459 Common Stock
Aug 05 2022	SELL Payment of exercise price or tax liability	$349,704 $32.41 p/Share	10,790 Reduced 25.39%	31,706 Common Stock
Aug 05 2022	BUY Exercise of conversion of derivative security	-	22,343 Added 34.46%	42,496 Common Stock
May 04 2022	SELL Payment of exercise price or tax liability	$92,357 $32.44 p/Share	2,847 Reduced 12.38%	20,153 Common Stock
May 04 2022	BUY Exercise of conversion of derivative security	-	8,310 Added 26.54%	23,000 Common Stock
Aug 05 2021	SELL Payment of exercise price or tax liability	$219,105 $28.63 p/Share	7,653 Reduced 34.25%	14,690 Common Stock
Aug 05 2021	BUY Exercise of conversion of derivative security	$639,680 $28.63 p/Share	22,343 Added 50.0%	22,343 Common Stock

Also insider at

CERT

Certara, Inc. Healthcare

MMW

Matthew M Walsh

Chief Financial Officer

Jersey City, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OGN shares.

Notify only if

Value

Insider Trading

Get notified when an Organon & Co. insider buys or sells OGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Organon & Co.

Track Activities on OGN

Account